Maternal lipids in pre-eclampsia: innocent bystander or culprit?

References

• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Carleton H, Forsythe A, Flores R. Remote prognosis of preeclampsia in women 25 years old and younger. Am J Obstet Gynecol 1988;159:156–60
   PubMed Web of Science ®Google Scholar
• Callaway LK, David McIntyre H, Williams GM, et al. Diagnosis and treatment of hypertension 21 years after a hypertensive disorder of pregnancy. Aust N Z J Obstetr Gynaecol 2011;51:437–40
   PubMedGoogle Scholar
• Hubel CA, Snaedal S, Ness RB, et al. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. BJOG 2000;107:776–84
   PubMedGoogle Scholar
• van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol 2005;48:489–94
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86
   PubMed Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes [see comment]. NEJM 2009;361:1339–48
   PubMed Web of Science ®Google Scholar
• Barrett HL, Dekker Nitert M, McIntyre HD, Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care 2014;37:1484–93
   PubMed Web of Science ®Google Scholar
• Roberts CL, Ford JB, Algert CS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 2011;1:e000101
   PubMed Web of Science ®Google Scholar
• Vlachadis N, Iliodromiti Z, Vrachnis N. The incidence of preeclampsia and eclampsia in Australia: 2000 through 2008. Am J Obstet Gynecol 2014;210:173–4
   PubMed Web of Science ®Google Scholar
• Thornton C, Dahlen H, Korda A, Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000–2008. Am J Obstet Gynecol 2013;208:476 e1–5
   PubMed Web of Science ®Google Scholar
• Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 2013;347:f6564
   PubMed Web of Science ®Google Scholar
• Roberts JM, Bodnar LM, Patrick TE, Powers RW. The role of obesity in preeclampsia. Pregnancy Hypertens 2011;1:6–16
   PubMed Web of Science ®Google Scholar
• Bilano VL, Ota E, Ganchimeg T, et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One 2014;9:e91198
   PubMed Web of Science ®Google Scholar
• Razzaghi H, Marcinkevage J, Peterson C. Prevalence of undiagnosed diabetes among non-pregnant women of reproductive age in the United States, 1999–2010. Primary Care Diabetes. 2013. [Epub ahead of print]. doi: 10.1016/j.pcd.2013.10.004
   Google Scholar
• Laz TH, Rahman M, Berenson AB. Trends in serum lipids and hypertension prevalence among non-pregnant reproductive-age women: United States National Health and Nutrition Examination Survey 1999-2008. Matern Child Health J 2013;17:1424–31
   PubMedGoogle Scholar
• Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008;18:186–94
   PubMed Web of Science ®Google Scholar
• Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000;54:S47–51
   PubMed Web of Science ®Google Scholar
• Charlton F, Tooher J, Rye KA, Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart, Lung Circ 2014;23:203–12
   PubMed Web of Science ®Google Scholar
• Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009;201:482 e1–8
   PubMed Web of Science ®Google Scholar
• Ziaei S, Bonab KM, Kazemnejad A. Serum lipid levels at 28–32 weeks gestation and hypertensive disorders. Hypertens Pregnancy 2006;25:3–10
   PubMed Web of Science ®Google Scholar
• Sep S, Rijvers C, Smits L, et al. Early-pregnancy changes in maternal lipid profile in women with recurrent preeclampsia and previously preeclamptic women with normal next pregnancy. Reprod Sci 2011;18:998–1004
   PubMed Web of Science ®Google Scholar
• Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006;113:379–86
   PubMed Web of Science ®Google Scholar
• Baker AM, Klein RL, Moss KL, et al. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 2009;201:293 e1–4
   Web of Science ®Google Scholar
• Enquobahrie DA, Williams MA, Butler CL, et al. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:574–81
   PubMed Web of Science ®Google Scholar
• Gallos ID, Sivakumar K, Kilby MD, et al. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG 2013;120:1321–32
   PubMedGoogle Scholar
• Punthumapol C, Kittichotpanich B. Comparative study of serum lipid concentrations in preeclampsia and normal pregnancy. J Med Assoc Thai 2008;91:957–61
   PubMedGoogle Scholar
• Chalas J, Audibert F, Francoual J, et al. Concentrations of apolipoproteins E, C2, and C3 and lipid profile in preeclampsia. Hypertens Pregnancy 2002;21:199–204
   PubMed Web of Science ®Google Scholar
• Alvino G, Cozzi V, Radaelli T, et al. Maternal and fetal fatty acid profile in normal and intrauterine growth restriction pregnancies with and without preeclampsia. Pediatr Res 2008;64:615–20
   PubMed Web of Science ®Google Scholar
• Sattar N, Bendomir A, Berry C, et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403–8
   PubMed Web of Science ®Google Scholar
• Lima VJ, Andrade CR, Ruschi GE, Sass N. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo medical journal = Revista paulista de medicina 2011;129:73–6
   PubMed Web of Science ®Google Scholar
• Ogura K, Miyatake T, Fukui O, et al. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 2002;9:42–7
   PubMedGoogle Scholar
• Belo L, Caslake M, Gaffney D, et al. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002;162:425–32
   PubMed Web of Science ®Google Scholar
• Bayhan G, Kocyigit Y, Atamer A, et al. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005;21:1–6
   PubMed Web of Science ®Google Scholar
• Domínguez C, Cabero L, Crispi F, et al. Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia. Metabolism 2005;54:1504–9
   PubMedGoogle Scholar
• Var A, Kuscu NK, Koyuncu F, et al. Atherogenic profile in preeclampsia. Arch Gynecol Obstet 2003;268:45–7
   PubMedGoogle Scholar
• Adiga U, D'Souza V, Kamath A, Mangalore N. Antioxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc 2007;70:435–8
   PubMedGoogle Scholar
• Kim YJ, Park H, Lee HY, et al. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007;133:47–52
   PubMed Web of Science ®Google Scholar
• Uzun H, Benian A, Madazli R, et al. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005;60:195–200
   PubMed Web of Science ®Google Scholar
• Acikgoz S, Bayar UO, Can M, et al. Levels of oxidized LDL, estrogens, and progesterone in placenta tissues and serum paraoxonase activity in preeclampsia. Mediat Inflamm 2013;2013:862982 (1–6)
   Google Scholar
• Pecks U, Caspers R, Schiessl B, et al. The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia. Hypertens Pregnancy 2012;31:156–65
   PubMed Web of Science ®Google Scholar
• Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009;50:S376–81
   PubMed Web of Science ®Google Scholar
• Staff AC, Dechend R, Redman CW. Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses [Review]. Placenta 2013;34:S73–8
   PubMed Web of Science ®Google Scholar
• Staff AC, Ranheim T, Khoury J, Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 1999;180:587–92
   PubMed Web of Science ®Google Scholar
• English FA, McCarthy FP, McSweeney CL, et al. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia. Am J Hypertens 2013;26:279–86
   PubMedGoogle Scholar
• Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension 2009;53:270–7
   PubMedGoogle Scholar
• Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011;58:709–15
   PubMed Web of Science ®Google Scholar
• Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010;28:1349–55
   PubMed Web of Science ®Google Scholar
• Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206–15
   PubMed Web of Science ®Google Scholar
• Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;285:1607–12
   PubMed Web of Science ®Google Scholar
• Sattar N, Ramsay J, Crawford L, et al. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003;42:39–42
   PubMed Web of Science ®Google Scholar
• Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012;125:1367–80
   PubMed Web of Science ®Google Scholar
• Callaway LK, Mamun A, McIntyre HD, et al. Does a history of hypertensive disorders of pregnancy help predict future essential hypertension? Findings from a prospective pregnancy cohort study. J Hum Hypertens 2013;27:309–14
   PubMedGoogle Scholar
• Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012;129:e1552–61
   PubMed Web of Science ®Google Scholar
• Mamun AA, Kinarivala MK, O'Callaghan M, et al. Does hypertensive disorder of pregnancy predict offspring blood pressure at 21 years? Evidence from a birth cohort study. J Hum Hypertens 2012;26:288–94
   PubMedGoogle Scholar
• Lazdam M, de la Horra A, Pitcher A, et al. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension 2010;56:159–65
   PubMed Web of Science ®Google Scholar
• Kvehaugen AS, Dechend R, Ramstad HB, et al. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011;58:63–9
   PubMed Web of Science ®Google Scholar
• Tenhola S, Rahiala E, Martikainen A, et al. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab 2003;88:1217–22
   PubMed Web of Science ®Google Scholar
• Miettola S, Hartikainen AL, Vaarasmaki M, et al. Offspring's blood pressure and metabolic phenotype after exposure to gestational hypertension in utero. Eur J Epidemiol 2013;28:87–98
   PubMed Web of Science ®Google Scholar
• Fraser A, Nelson SM, Macdonald-Wallis C, et al. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 2013;62:614–20
   PubMed Web of Science ®Google Scholar
• Kajantie E, Eriksson JG, Osmond C, et al. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176–80
   PubMed Web of Science ®Google Scholar
• Wu CS, Nohr EA, Bech BH, et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol 2009;201:269 e1–e10
   PubMed Web of Science ®Google Scholar
• Toleikyte I, Retterstol K, Leren TP, Iversen PO. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Circulation 2011;124:1606–14
   PubMed Web of Science ®Google Scholar
• Hill AJ, Pacheco LD, Saade G, Hankins GD. Familial hypertriglyceridemia in pregnancy. Int J Gynaecol Obstet 2014;125:80–1
   PubMedGoogle Scholar
• Glueck CJ, Streicher P, Wang P, et al. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition 1996;12:202–5
   PubMedGoogle Scholar
• Poon LC, Kametas NA, Chelemen T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2010;24:104–10
   PubMed Web of Science ®Google Scholar
• Nilsson E, Salonen Ros H, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 2004;111:200–6
   PubMed Web of Science ®Google Scholar
• Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000;91:256–60
   PubMed Web of Science ®Google Scholar
• Lachmeijer AM, Aarnoudse JG, ten Kate LP, et al. Concordance for pre-eclampsia in monozygous twins. Br J Obstet Gynaecol 1998;105:1315–17
   PubMedGoogle Scholar
• O'Shaughnessy KM, Ferraro F, Fu B, et al. Identification of monozygotic twins that are concordant for preeclampsia. Am J Obstet Gynecol 2000;182:1156–7
   PubMedGoogle Scholar
• Thornton JG, Macdonald AM. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 1999;106:570–5
   PubMedGoogle Scholar
• Treloar SA, Cooper DW, Brennecke SP, et al. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol 2001;184:374–81
   PubMedGoogle Scholar
• Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004;130A:365–71
   PubMed Web of Science ®Google Scholar
• Zhao L, Bracken MB, Dewan AT. Genome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the hyperglycemia and adverse pregnancy outcome (HAPO) study cohort. Ann Hum Genet 2013;77:277–87
   Google Scholar
• Zhao L, Triche EW, Walsh KM, et al. Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth 2012;12:61
   PubMed Web of Science ®Google Scholar
• Johnson MP, Brennecke SP, East CE, et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS One 2012;7:e33666
   PubMedGoogle Scholar
• Staines-Urias E, Paez MC, Doyle P, et al. Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Int J Epidemiol 2012;41:1764–75
   PubMed Web of Science ®Google Scholar
• Buurma AJ, Turner RJ, Driessen JH, et al. Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update 2013;19:289–303
   PubMed Web of Science ®Google Scholar
• Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. J Perinat Med 2008;36:38–58
   PubMed Web of Science ®Google Scholar
• Sagoo GS, Tatt I, Salanti G, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 2008;168:1233–46
   PubMed Web of Science ®Google Scholar
• Hubel CA, Roberts JM, Ferrell RE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 1999;56:289–96
   PubMed Web of Science ®Google Scholar
• Kim YJ, Williamson RA, Chen K, et al. Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 2001;38:992–6
   PubMed Web of Science ®Google Scholar
• Zhang C, Austin MA, Edwards KL, et al. Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women. Clin Genet 2006;69:33–9
   PubMed Web of Science ®Google Scholar
• Procopciuc LM, Stamatian F, Caracostea G. LPL Ser447Ter and Asn291Ser variants in Romanians: associations with preeclampsia – implications on lipid profile and prognosis. Hypertens Pregnancy 2014;33:15–30
   PubMed Web of Science ®Google Scholar
• Nagy B, Rigo JJr, Fintor L, et al. Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol 1998;51:324–5
   PubMed Web of Science ®Google Scholar
• Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723–31
   PubMed Web of Science ®Google Scholar
• Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998;178:603–8
   PubMed Web of Science ®Google Scholar
• Mutze S, Ahillen I, Rudnik-Schoeneborn S, et al. Neither maternal nor fetal mutation (E474Q) in the alpha-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome. J Perinat Med 2007;35:76–8
   PubMedGoogle Scholar
• den Boer ME, Ijlst L, Wijburg FA, et al. Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000;48:151–4
   PubMedGoogle Scholar
• Henderson JT, Whitlock EP, O'Connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695–703
   Google Scholar
• Imhoff-Kunsch B, Briggs V, Goldenberg T, Ramakrishnan U. Effect of n-3 long-chain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: a systematic review. Paediatr Perinat Epidemiol 2012;26:91–107
   PubMed Web of Science ®Google Scholar
• Rogers LK, Valentine CJ, Keim SA. DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 2013;70:13–19
   PubMed Web of Science ®Google Scholar
• Larque E, Gil-Sanchez A, Prieto-Sanchez MT, Koletzko B. Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr 2012;107:S77–84
   PubMed Web of Science ®Google Scholar
• Jones ML, Mark PJ, Waddell BJ. Maternal dietary omega-3 fatty acids and placental function. Reproduction 2014;147:R143–52
   PubMed Web of Science ®Google Scholar
• Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995;6:232–7
   PubMed Web of Science ®Google Scholar
• Al MD, van Houwelingen AC, Badart-Smook A, et al. The essential fatty acid status of mother and child in pregnancy-induced hypertension: a prospective longitudinal study. Am J Obstet Gynecol 1995;172:1605–14
   PubMedGoogle Scholar
• Qiu C, Sanchez SE, Larrabure G, et al. Erythrocyte omega-3 and omega-6 polyunsaturated fatty acids and preeclampsia risk in Peruvian women. Arch Gynecol Obstet 2006;274:97–103
   PubMedGoogle Scholar
• Mahomed K, Williams MA, King IB, et al. Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res 2007;56:37–50
   PubMed Web of Science ®Google Scholar
• Olafsdottir AS, Skuladottir GV, Thorsdottir I, et al. Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy. BJOG 2006;113:301–9
   PubMed Web of Science ®Google Scholar
• Adair CD, Sanchez-Ramos L, Briones DL, Ogburn PJr. The effect of high dietary n-3 fatty acid supplementation on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol 1996;175:688–91
   PubMedGoogle Scholar
• Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;(3):CD003402
   Google Scholar
• Morton S, Thangaratinam S. Statins in pregnancy. Curr Opin Obstet Gynecol 2013;25:433–40
   PubMed Web of Science ®Google Scholar
• Girardi G. Can statins prevent pregnancy complications? J Reprod Immunol 2014;101–102:161–7
   PubMedGoogle Scholar
• Lecarpentier E, Morel O, Fournier T, et al. Statins and pregnancy: between supposed risks and theoretical benefits. Drugs 2012;72:773–88
   PubMedGoogle Scholar
• Nanovskaya TN, Patrikeeva SL, Paul J, et al. Transplacental transfer and distribution of pravastatin. Am J Obstet Gynecol 2013;209:373 e1–5
   PubMed Web of Science ®Google Scholar
• Kusters DM, Lahsinoui HH, van de Post JA, et al. Statin use during pregnancy: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther 2012;10:363–78
   PubMedGoogle Scholar
• Ahmed A. Statins to ameliorate early onset pre-eclampsia. 2013. Available from: http://www.controlled-trials.com/ISRCTN23410175 [last accessed 21 Jan 2013]
   Google Scholar
• Costantine MM, Cleary K, Eunice Kennedy Shriver National Institute of Child H, Human Development Obstetric–Fetal Pharmacology Research Units N. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 2013;121:349–53
   PubMed Web of Science ®Google Scholar
• Basar R, Uzum AK, Canbaz B, et al. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy. Arch Gynecol Obstet 2013;287:839–43
   PubMed Web of Science ®Google Scholar
• Sivakumaran P, Tabak SW, Gregory K, et al. Management of familial hypertriglyceridemia during pregnancy with plasma exchange. J Clin Apheresis 2009;24:42–6
   PubMed Web of Science ®Google Scholar
• Cashin-Hemphill L, Noone M, Abbott JF, et al. Low-density lipoprotein apheresis therapy during pregnancy. Am J Cardiol 2000;86:1160
   PubMedGoogle Scholar
• Thadhani R, Kisner T, Hagmann H, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011;124:940–50
   PubMed Web of Science ®Google Scholar
• Wang Y, Walli AK, Schulze A, et al. Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus Apher Sci 2006;35:103–10
   PubMed Web of Science ®Google Scholar